Condition: Obesity, Childhood · Type 2 Diabetes Mellitus in Obese · Sponsor: Philippe Klee, MD-PhD
The investigators will measure blood levels of 1,5-anhydroglucitol in obese children with or without type 2 diabetes and correlate them with parameters related to functional beta-cell mass and glucose metabolism. The values will be compared to those obtained in healthy volunteers. The aim of the study is to test the validity of 1,5-anhydroglucitol as a novel biomarker of beta-cell mass and function in children with obesity with or without type 2 diabetes.
This description comes directly from the study's public registry record.
Philippe Klee · +41 79 55 33 476 · philippe.klee@unige.ch
Pierre Maechler · pierre.maechler@unige.ch
Always discuss trial participation with your own doctor first.
| University Hospital of Geneva | Geneva, Canton of Geneva, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06682481